相关实验视频
Updated: Jul 20, 2025
05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
253
[基于核医学的阿尔茨海默病早期诊断]
1Team for Neuroimaging Research, Tokyo Metropolitan Institute of Gerontology.
Brain and nerve = Shinkei kenkyu no shinpo
|August 4, 2023
概括
核医学成像,包括粉样质正电子发射断层扫描 (PET) 和质PET,可以早期诊断阿尔茨海默病. 这些进展对于了解疾病进展和开发新疗法至关重要.
科学领域:
- 核医学是一种核医学.
- 神经学 神经学
- 放射化学 放射化学是指辐射化学.
背景情况:
- 阿尔茨海默病的诊断传统上依赖于临床评估和脑脊液分析.
- 早期和症状前检测对于及时干预和疾病管理至关重要.
- 需要病理特异性诊断工具来提高诊断准确性和患者的治疗结果.
研究的目的:
- 审查核医学诊断的现状,以早期检测阿尔茨海默病.
- 讨论这些成像生物标志物在阿尔茨海默病研究和临床实践中的未来前景.
- 突出核医学在加速开发阿尔茨海默氏症疾病修饰疗法的作用.
主要方法:
- 对阿尔茨海默病中的粉样PET和PET成像现有文献的综述.
- 分析成像生物标志物的作用,以了解阿尔茨海默病的发病因子.
- 讨论核医学在促进新阿尔茨海默氏症药物的临床试验方面的潜力.
主要成果:
- 粉样PET和粉样PET是用于检测核心阿尔茨海默氏症病理学的已知工具.
- 这些成像技术允许早期和症状前诊断阿尔茨海默病.
- 核医学成像在临床试验的患者分层和监测治疗反应方面起着重要作用.
结论:
- 核医学诊断在早期发现和管理阿尔茨海默病方面取得了重大进展.
- 在成像生物标志物的持续研究和开发将进一步完善诊断能力和治疗策略.
- 核医学在常规临床实践中的整合有望延迟和预防阿尔茨海默病的进展.
相关概念视频
01:26Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
01:22Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215